Nexalin Technology, Inc. SEC filings NXL
Nexalin Technology, Inc. has 204 filings in SEC EDGAR's recent list, going back to Aug 9, 2011. Its latest annual report, Form ARS, was filed on Jul 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 15, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 4, 2025 | — |
| CORRESP | Letter to the SEC | Sep 23, 2025 | — |
| 25-NSE | Delisting notice | Sep 19, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| EFFECT | Filing | Apr 29, 2025 | — |
| CORRESP | Letter to the SEC | Apr 28, 2025 | — |
| DRSLTR | Filing | Apr 10, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2025 | — |
| DRS | Filing | Mar 31, 2025 | — |
| EFFECT | Filing | Feb 3, 2025 | — |
| CORRESP | Letter to the SEC | Jan 30, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 3, 2025 | — |
| EFFECT | Filing | Jun 27, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2024 | — |
| CORRESP | Letter to the SEC | Jun 12, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 5, 2024 | — |
| RW | Filing | May 14, 2024 | — |
| CERT | Filing | Sep 16, 2022 | — |
| EFFECT | Filing | Sep 15, 2022 | — |
| 8-A12B | Filing | Sep 15, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 12, 2022 | — |
| CORRESP | Letter to the SEC | May 31, 2022 | — |
| CORRESP | Letter to the SEC | May 16, 2022 | — |
| UPLOAD | Letter from the SEC | May 6, 2022 | — |
| CORRESP | Letter to the SEC | Apr 27, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2022 | — |
| CORRESP | Letter to the SEC | Apr 8, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2021 | — |
| DRS/A | Filing | Dec 8, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2021 | — |
| DRS/A | Filing | Nov 2, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2021 | — |
| DRS | Filing | Sep 17, 2021 | — |
| D | Filing | Aug 9, 2011 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NXL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1527352
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.